๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Results of a phase III trial of IM recombinant beta interferon as treatment for MS

โœ Scribed by L. Jacobs; D. Cookfair; R. Rudick; R. Herndon; J. Richert; A. Salazar

Book ID
119109004
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
150 KB
Volume
54
Category
Article
ISSN
0165-5728

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Results of a phase-II clinical trial on
Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma
โœ E. M. Lemmel; M. Franke; W. Gaus; P. W. Hartl; P. H. Hofschneider; K. Miehlke; K ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 552 KB

In an open, non-randomized clinical trial conducted at multiple centres, 49 patients with rheumatoid arthritis were treated with recombinant interferon-gamma for 20 days. The study was carried out in two sub-studies. In the first, the total daily dose of interferon-gamma was 50 micrograms; in the se

Results of a multicenter placebo-control
Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma
โœ E. M. Lemmel; D. Brackertz; M. Franke; W. Gaus; P. W. Hartl; K. Machalke; H. Mie ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 660 KB

In a multicenter placebo-controlled double-blind randomized clinical study, 91 patients with rheumatoid arthritis were given 28 days' treatment with recombinant interferon-gamma (50 micrograms daily for 20 days, then 50 micrograms each second day up to day 28, given by subcutaneous injection). The a